rs3213784

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001875.5(CPS1):​c.3405-29A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.407 in 1,580,844 control chromosomes in the GnomAD database, including 133,577 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). There are indicators that this mutation may affect the branch point..

Frequency

Genomes: 𝑓 0.38 ( 11787 hom., cov: 32)
Exomes 𝑓: 0.41 ( 121790 hom. )

Consequence

CPS1
NM_001875.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: 2.81

Publications

14 publications found
Variant links:
Genes affected
CPS1 (HGNC:2323): (carbamoyl-phosphate synthase 1) The mitochondrial enzyme encoded by this gene catalyzes synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, which is important in the removal of excess urea from cells. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been found for this gene. The shortest isoform may not be localized to the mitochondrion. Mutations in this gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation.[provided by RefSeq, May 2010]
CPS1 Gene-Disease associations (from GenCC):
  • carbamoyl phosphate synthetase I deficiency disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Myriad Women’s Health, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
This position, referring to a specific DNA site, is a probable branch point but rather VUS (scored 5 / 10). The score ranges from 0 to 10, with values ≤3 considered benign and >5 classified as pathogenic. Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 2-210650334-A-T is Benign according to our data. Variant chr2-210650334-A-T is described in ClinVar as Benign. ClinVar VariationId is 258479.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.504 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001875.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
NM_001875.5
MANE Select
c.3405-29A>T
intron
N/ANP_001866.2
CPS1
NM_001369256.1
c.3438-29A>T
intron
N/ANP_001356185.1
CPS1
NM_001122633.3
c.3405-29A>T
intron
N/ANP_001116105.2P31327-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CPS1
ENST00000233072.10
TSL:1 MANE Select
c.3405-29A>T
intron
N/AENSP00000233072.5P31327-1
CPS1
ENST00000430249.7
TSL:1
c.3423-29A>T
intron
N/AENSP00000402608.2P31327-3
CPS1
ENST00000451903.3
TSL:1
c.2052-29A>T
intron
N/AENSP00000406136.2P31327-2

Frequencies

GnomAD3 genomes
AF:
0.384
AC:
58362
AN:
151796
Hom.:
11785
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.270
Gnomad AMI
AF:
0.340
Gnomad AMR
AF:
0.467
Gnomad ASJ
AF:
0.333
Gnomad EAS
AF:
0.521
Gnomad SAS
AF:
0.421
Gnomad FIN
AF:
0.481
Gnomad MID
AF:
0.304
Gnomad NFE
AF:
0.411
Gnomad OTH
AF:
0.397
GnomAD2 exomes
AF:
0.425
AC:
106621
AN:
250998
AF XY:
0.423
show subpopulations
Gnomad AFR exome
AF:
0.270
Gnomad AMR exome
AF:
0.503
Gnomad ASJ exome
AF:
0.332
Gnomad EAS exome
AF:
0.520
Gnomad FIN exome
AF:
0.480
Gnomad NFE exome
AF:
0.407
Gnomad OTH exome
AF:
0.410
GnomAD4 exome
AF:
0.410
AC:
585457
AN:
1428928
Hom.:
121790
Cov.:
27
AF XY:
0.408
AC XY:
291302
AN XY:
713138
show subpopulations
African (AFR)
AF:
0.263
AC:
8635
AN:
32798
American (AMR)
AF:
0.502
AC:
22378
AN:
44594
Ashkenazi Jewish (ASJ)
AF:
0.340
AC:
8821
AN:
25920
East Asian (EAS)
AF:
0.499
AC:
19695
AN:
39496
South Asian (SAS)
AF:
0.414
AC:
35452
AN:
85570
European-Finnish (FIN)
AF:
0.479
AC:
25529
AN:
53352
Middle Eastern (MID)
AF:
0.289
AC:
1650
AN:
5712
European-Non Finnish (NFE)
AF:
0.406
AC:
439527
AN:
1082278
Other (OTH)
AF:
0.401
AC:
23770
AN:
59208
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
17782
35564
53347
71129
88911
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13444
26888
40332
53776
67220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.384
AC:
58395
AN:
151916
Hom.:
11787
Cov.:
32
AF XY:
0.389
AC XY:
28906
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.270
AC:
11186
AN:
41458
American (AMR)
AF:
0.467
AC:
7125
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.333
AC:
1153
AN:
3464
East Asian (EAS)
AF:
0.521
AC:
2679
AN:
5144
South Asian (SAS)
AF:
0.421
AC:
2027
AN:
4814
European-Finnish (FIN)
AF:
0.481
AC:
5082
AN:
10556
Middle Eastern (MID)
AF:
0.286
AC:
84
AN:
294
European-Non Finnish (NFE)
AF:
0.411
AC:
27916
AN:
67908
Other (OTH)
AF:
0.395
AC:
834
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1796
3592
5389
7185
8981
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
564
1128
1692
2256
2820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.387
Hom.:
2126
Bravo
AF:
0.378
Asia WGS
AF:
0.456
AC:
1584
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (3)
-
-
2
not specified (2)
-
-
1
Congenital hyperammonemia, type I (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
17
DANN
Benign
0.60
PhyloP100
2.8
La Branchor
0.84
BranchPoint Hunter
5.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3213784; hg19: chr2-211515058; COSMIC: COSV51811843; COSMIC: COSV51811843; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.